Medical Technology

Current search: " boston top stories "

@xconomy.com 2 days ago

Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later

@xconomy.com 23 days ago

CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”

@xconomy.com 1 month ago

HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic

@xconomy.com 1 month ago

Join us this Wednesday for Xcelerating Life Sciences: Biopharma’s Future in Digital Health

@xconomy.com 1 month ago

Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health

@xconomy.com 1 month ago

Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health

@xconomy.com 1 month ago

Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs

@xconomy.com 1 month ago

Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health

@xconomy.com 2 months ago

Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses

@xconomy.com 2 months ago

Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health

@xconomy.com 2 months ago

Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health

@xconomy.com 2 months ago

Early Bird Sale Ends Today for Xcelerating Life Sciences Boston: Biopharma’s Future in Digital Health

@xconomy.com 2 months ago

Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More

@xconomy.com 4 months ago

EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device

@xconomy.com 4 months ago

Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks

@xconomy.com 4 months ago

Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer

@xconomy.com 5 months ago

Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy

@xconomy.com 5 months ago

Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More

@xconomy.com 5 months ago

With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14

@xconomy.com 5 months ago

Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus

@xconomy.com 5 months ago

Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers

@xconomy.com 5 months ago

Schrödinger Sets Course for IPO to Support Growing Internal Pipeline

@xconomy.com 5 months ago

Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy

@xconomy.com 5 months ago

Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic

@xconomy.com 6 months ago

Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal

@xconomy.com 7 months ago

Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B

@xconomy.com 8 months ago

Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug

@xconomy.com 8 months ago

Disc Medicine Launches With $50M to Advance New Anemia Treatments

@xconomy.com 8 months ago

Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More

@xconomy.com 8 months ago

Bio Roundup: Nobel Prizes, Placebo Effect Rises, ICER’s Fire & More

@xconomy.com 8 months ago

UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma

@xconomy.com 8 months ago

Five Years After Y Combinator First Admits Biotechs, They’re Dug In

@xconomy.com 8 months ago

Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels

@xconomy.com 9 months ago

ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More

@xconomy.com 9 months ago

Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More

@xconomy.com 9 months ago

MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests

@xconomy.com 9 months ago

Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further

@xconomy.com 9 months ago

Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?

@xconomy.com 9 months ago

After First Look at House Drug Plan, Stocks Rise Slightly